Secukinumab is the most efficient treatment for achieving clear skin in psoriatic patients: a cost-consequence study from the Spanish National Health Service-Reference-Cited by-同舟云学术

Secukinumab is the most efficient treatment for achieving clear skin in psoriatic patients: a cost-consequence study from the Spanish National Health Service

Published:2017-10-03 Issue:7 Volume:28 Page:623-630
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Puig Lluís¹^ORCID,Notario Jaume²,Jiménez-Morales Alberto³,Moreno-Ramírez David⁴,López-Ferrer Anna¹,Gozalbo Irmina⁵,Prades Míriam⁵,Lizán Luis⁵,Blanch Carles⁶

Affiliation:

1. Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain;

2. Department of Dermatology, Hospital Universitari de Bellvitge, Feixa Llarga, Barcelona, Spain;

3. Department of Pharmacy, Hospital Virgen de las Nieves de Granada, Spain;

4. Medical and Surgical Dermatology Unit, Hospital Universitario Virgen Macarena, Sevilla, Spain;

5. Outcomes SL. Castelló de la Plana, Castellón, Spain;

6. Novartis Pharmaceuticals, Barcelona, Spain

Publisher

Informa UK Limited

Subject

Dermatology

Link